US shock for Lupin shares

Drug firm Lupin has received a warning letter from the US health regulator for its manufacturing facilities in Goa and Indore (Pithampur Unit II) .

OUR SPECIAL CORRESPONDENT

Published 08.11.17, 12:00 AM